XML 50 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated and combined balance sheets (USD $)
Dec. 31, 2014
Dec. 31, 2013
Current assets    
Cash and cash equivalents (Note 4) $ 14,906,087us-gaap_CashAndCashEquivalentsAtCarryingValue $ 11,006,392us-gaap_CashAndCashEquivalentsAtCarryingValue
Short-term investments (Note 14) 24,191,219us-gaap_AvailableForSaleSecuritiesCurrent 2,820,600us-gaap_AvailableForSaleSecuritiesCurrent
Accounts and other amounts receivable (Note 5) 65,447us-gaap_AccountsAndOtherReceivablesNetCurrent 27,946us-gaap_AccountsAndOtherReceivablesNetCurrent
Prepayments and deposits 139,006aqxp_PrepaymentsAndDepositsCurrent 63,975aqxp_PrepaymentsAndDepositsCurrent
Deferred offering costs   1,377,438us-gaap_DeferredOfferingCosts
Total current assets 39,301,759us-gaap_AssetsCurrent 15,296,351us-gaap_AssetsCurrent
Property and equipment, net (Note 6) 104,694us-gaap_PropertyPlantAndEquipmentNet 75,465us-gaap_PropertyPlantAndEquipmentNet
Long-term investments (Note 14) 2,003,099us-gaap_AvailableForSaleSecuritiesNoncurrent  
Other 13,395us-gaap_OtherAssetsNoncurrent 277,290us-gaap_OtherAssetsNoncurrent
Total assets 41,422,947us-gaap_Assets 15,649,106us-gaap_Assets
Current liabilities    
Accounts payable and accrued liabilities (Note 7) 5,203,308us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent 2,350,660us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Current portion of bank loan (Note 8)   250,000us-gaap_LoansPayableToBankCurrent
Other   19,445us-gaap_OtherLiabilitiesCurrent
Total current liabilities 5,203,308us-gaap_LiabilitiesCurrent 2,620,105us-gaap_LiabilitiesCurrent
Warrant liabilities (Note 10) 72,341us-gaap_DerivativeLiabilitiesNoncurrent 221,320us-gaap_DerivativeLiabilitiesNoncurrent
Redemption option on preferred stock (Note 14)   800,206aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption
Accrued tax payable on preferred stock (Note 13) 0us-gaap_DeferredTaxLiabilitiesNoncurrent 1,797,412us-gaap_DeferredTaxLiabilitiesNoncurrent
Bank loan (Note 8)   2,036,489us-gaap_LongTermLoansFromBank
Other   8,560us-gaap_OtherLiabilitiesNoncurrent
Total liabilities 5,275,649us-gaap_Liabilities 7,484,092us-gaap_Liabilities
Redeemable convertible preferred stock (Note 9)    
Redeemable convertible preferred stock   73,858,722us-gaap_TemporaryEquityCarryingAmountAttributableToParent
Commitments and contingencies (Note 16)      
Common stock (Note 11)    
Common stock 11us-gaap_CommonStockValue  
Preferred stock (Note 9)    
Preferred stock      
Additional paid-in capital 125,566,705us-gaap_AdditionalPaidInCapital  
Accumulated deficit (89,415,563)us-gaap_RetainedEarningsAccumulatedDeficit (65,693,708)us-gaap_RetainedEarningsAccumulatedDeficit
Accumulated other comprehensive income (3,855)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax  
Total stockholders' equity (deficit) 36,147,298us-gaap_StockholdersEquity (65,693,708)us-gaap_StockholdersEquity
Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit) 41,422,947us-gaap_LiabilitiesAndStockholdersEquity 15,649,106us-gaap_LiabilitiesAndStockholdersEquity
Series A Preferred Stock [Member]    
Redeemable convertible preferred stock (Note 9)    
Redeemable convertible preferred stock 0us-gaap_TemporaryEquityCarryingAmountAttributableToParent
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesAPreferredStockMember
11,157,138us-gaap_TemporaryEquityCarryingAmountAttributableToParent
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesAPreferredStockMember
Series B Preferred Stock [Member]    
Redeemable convertible preferred stock (Note 9)    
Redeemable convertible preferred stock   21,091,150us-gaap_TemporaryEquityCarryingAmountAttributableToParent
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesBPreferredStockMember
Series C Preferred Stock [Member]    
Redeemable convertible preferred stock (Note 9)    
Redeemable convertible preferred stock   13,765,741us-gaap_TemporaryEquityCarryingAmountAttributableToParent
/ us-gaap_StatementClassOfStockAxis
= us-gaap_SeriesCPreferredStockMember
Aquinox Pharmaceuticals (Canada) Inc. [Member] | Series A Exchangeable Preferred Shares [Member]    
Redeemable convertible preferred stock (Note 9)    
Redeemable convertible preferred stock   13,329,639us-gaap_TemporaryEquityCarryingAmountAttributableToParent
/ dei_LegalEntityAxis
= aqxp_AqxpCanadaMember
/ us-gaap_StatementClassOfStockAxis
= aqxp_SeriesAExchangeablePreferredStockMember
Aquinox Pharmaceuticals (Canada) Inc. [Member] | Series B Exchangeable Preferred Shares [Member]    
Redeemable convertible preferred stock (Note 9)    
Redeemable convertible preferred stock   10,684,093us-gaap_TemporaryEquityCarryingAmountAttributableToParent
/ dei_LegalEntityAxis
= aqxp_AqxpCanadaMember
/ us-gaap_StatementClassOfStockAxis
= aqxp_SeriesBExchangeablePreferredStockMember
Aquinox Pharmaceuticals (Canada) Inc. [Member] | Series C Exchangeable Preferred Shares [Member]    
Redeemable convertible preferred stock (Note 9)    
Redeemable convertible preferred stock   $ 3,830,961us-gaap_TemporaryEquityCarryingAmountAttributableToParent
/ dei_LegalEntityAxis
= aqxp_AqxpCanadaMember
/ us-gaap_StatementClassOfStockAxis
= aqxp_SeriesCExchangeablePreferredStockMember